LATRONICO, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 2.230
EU - Europa 706
AS - Asia 370
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.312
Nazione #
US - Stati Uniti d'America 2.219
CN - Cina 267
SE - Svezia 191
IT - Italia 163
SG - Singapore 97
DE - Germania 74
UA - Ucraina 63
FI - Finlandia 46
RU - Federazione Russa 44
FR - Francia 41
GB - Regno Unito 35
BE - Belgio 17
CA - Canada 10
IE - Irlanda 10
CZ - Repubblica Ceca 8
NL - Olanda 5
AU - Australia 4
JP - Giappone 3
HU - Ungheria 2
IN - India 2
LT - Lituania 2
AT - Austria 1
BY - Bielorussia 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
KR - Corea 1
MX - Messico 1
PE - Perù 1
PL - Polonia 1
Totale 3.312
Città #
Woodbridge 274
Chandler 257
Fairfield 214
Houston 164
Ashburn 160
Nyköping 160
Jacksonville 145
Ann Arbor 144
Wilmington 98
Cambridge 85
Seattle 85
Singapore 83
Beijing 61
Bari 55
Lawrence 49
Roxbury 47
Nanjing 38
New York 35
Marseille 33
Boardman 31
Des Moines 26
Brussels 17
Jiaxing 16
Spongano 15
Brooklyn 14
Princeton 13
Inglewood 12
Falls Church 11
Guangzhou 11
Wuhan 11
Dublin 10
Munich 10
San Diego 10
Santa Clara 10
Shenyang 10
Changsha 9
Hebei 9
Los Angeles 9
Shanghai 9
Tianjin 8
Auburn Hills 7
Nanchang 7
Helsinki 6
Paris 6
Rome 6
Adelfia 5
Brno 5
Giovinazzo 5
Scottsdale 5
Amsterdam 4
Dearborn 4
Toronto 4
Washington 4
Wuxi 4
Brooks 3
Grottaglie 3
London 3
Palermo 3
San Francisco 3
Taranto 3
Aversa 2
Civitanova Marche 2
Fuzhou 2
Gothenburg 2
Grafing 2
Heze 2
Indiana 2
Jinan 2
Kilburn 2
Lecce 2
Melbourne 2
Milan 2
Miskolc 2
Molfetta 2
Ningbo 2
Norwalk 2
Nuremberg 2
Olomouc 2
Romola 2
Sydney 2
Taizhou 2
Triggiano 2
Zhengzhou 2
Augusta 1
Bergamo 1
Boston 1
Brampton 1
Brindisi 1
Capua 1
Cerignola 1
Ceska 1
Chiswick 1
Chizhou 1
Falkenstein 1
Foshan 1
Frankfurt am Main 1
Hanover 1
Hounslow 1
Hyderabad 1
Jinhua 1
Totale 2.611
Nome #
Integrin-targeting with peptide-bioconjugated semiconductor-magnetic nanocrystalline heterostructures 169
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 114
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 114
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 104
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 100
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 98
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 94
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 91
null 91
null 90
null 87
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 86
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 79
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 79
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 76
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 74
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 74
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 66
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 66
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 65
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 62
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 62
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 59
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 58
Inhibition of myelin-cleaving proteolytic activities by interferon-beta in rat astrocyte cultures. Comparative analysis between gelatinases and calpain-II. 58
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 56
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 56
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 55
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 53
Matrix Metalloproteinases in CNS Inflammation. 52
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 51
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 51
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 49
null 47
The effects of dietary antioxidants on gelatinase activity in cultured rat astrocytes. implications for the complementary treatment of multiple sclerosis. 47
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 46
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 46
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 45
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 39
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 39
High surface area mesoporous silica nanoparticles with tunable size in the sub-micrometer regime: Insights on the size and porosity control mechanisms 38
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 33
Inhibition of calpain activity and expression by interferon-beta in rat astrocytes: implications for MS pathogenesis and treatment. 32
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 30
Interferon-Beta Treatment Inhibits Matrix metalloproteinases in rat glial cell cultures 29
Interferon-alpha/beta treatment inhibits metalloproteinase activity in rat astrocyte cell cultures 29
Unravelling the relevance of fad synthetase in human physiopathology. A biotechnological approach. 29
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 28
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 27
DEVELOPMENTAL OMEGA-3 SUPPLEMENTATION IMPROVES MOTOR SKILLS IN JUVENILE RATS 24
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 22
Impact of manganese neurotoxicity on MMP-9 production and superoxide dismutase activity in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 21
null 21
Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies 21
Differential Modulation of NF-κ B in Neurons and Astrocytes Underlies Neuroprotection and Antigliosis Activity of Natural Antioxidant Molecules 18
null 18
Neuroprotective potential of isothiocyanates in an in vitro model of neuroinflammation 17
null 15
Inhibitory effect of immunomodulatory and immunosuppressive therapies on the activity of gelatinases and urokinase-type plasminogen activator in peripheral blood mononuclear cells from patients with multiple sclerosis 14
Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases 13
Intra- and interspecific variation in electrophoretic profiles of Tethya spp.: an integration to morfological classification system 11
Antioxidant Activity of Polysaccharides from the Edible Mushroom Pleurotus eryngii 11
Use of a commercial feed supplement based on yeast products and microalgae with or without nucleotide addition in calves 10
Molecular mechanisms of cell toxicity and Matrix Metalloproteinase-9 inhibition by Antiretroviral Drugs in Cultured Primary Astrocytes. 10
Lead exposure of rats during and after pregnancy induces anti-myelin proteolytic activity: a potential mechanism for lead-induced neurotoxicity 10
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects 8
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients 8
Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species 8
COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality 6
Neuroprotective Effect of Resveratrol against Manganese-Induced Oxidative Stress and Matrix Metalloproteinase-9 in an “In Vivo” Model of Neurotoxicity 6
Resveratrol impinges on retrograde communication without inducing mitochondrial biogenesis in aged rat soleus muscle 4
Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia 4
Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19 4
Metalloproteinases and their inhibitors as therapeutic targets for multiple sclerosis: current evidence and future perspectives 4
Increasing Oxygen Partial Pressures Induce a Distinct Transcriptional Response in Human PBMC: A Pilot Study on the "Normobaric Oxygen Paradox" 3
Totale 3.434
Categoria #
all - tutte 15.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020285 0 0 0 0 0 0 54 42 64 55 63 7
2020/2021395 39 14 37 15 43 12 33 34 48 66 42 12
2021/2022373 10 51 2 5 19 24 12 20 49 29 54 98
2022/2023752 77 79 53 68 86 96 9 91 131 33 15 14
2023/2024281 17 49 13 60 23 63 4 2 5 11 6 28
2024/2025378 111 29 72 34 44 72 16 0 0 0 0 0
Totale 3.434